Naonori Hu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Quality Control

Top Venues

Biomedical physics & engineering express

Neuro-oncology advances

This page only lists publications with an associated author ORCID identifier.

Publications

Yoshiki Fujikawa, Shinji Kawabata, Kohei Tsujino, Hironori Yamada, Hideki Kashiwagi, Ryokichi Yagi, Ryo Hiramatsu, Naosuke Nonoguchi, Toshihiro Takami, Akinori Sasaki, Naonori Hu, Takushi Takata, Hiroki Tanaka, Minoru Suzuki, Masahiko Wanibuchi
Boron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors. Cancer science (2024)
Yoshiki Fujikawa, Shinji Kawabata, Kohei Tsujino, Hironori Yamada, Hideki Kashiwagi, Ryokichi Yagi, Ryo Hiramatsu, Naosuke Nonoguchi, Toshihiro Takami, Akinori Sasaki, Naonori Hu, Takushi Takata, Hiroki Tanaka, Minoru Suzuki, Masahiko Wanibuchi
Boron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors. Cancer science 115 (8) (2024)
Yoshiki Fujikawa, Shinji Kawabata, Kohei Tsujino, Hironori Yamada, Hideki Kashiwagi, Ryokichi Yagi, Ryo Hiramatsu, Naosuke Nonoguchi, Toshihiro Takami, Akinori Sasaki, Naonori Hu, Takushi Takata, Hiroki Tanaka, Minoru Suzuki, Masahiko Wanibuchi
Boron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors. Cancer science 115 (8) (2024)
Kohei Tsujino, Hideki Kashiwagi, Kai Nishimura, Yoshiki Fujikawa, Ryo Kayama, Yusuke Fukuo, Ryo Hiramatsu, Naosuke Nonoguchi, Takushi Takata, Hiroki Tanaka, Minoru Suzuki, Naonori Hu, Koji Ono, Masahiko Wanibuchi, Kei Nakai, Hiroyuki Nakamura, Shinji Kawabata
Nonclinical pharmacodynamics of boron neutron capture therapy using direct intratumoral administration of a folate receptor targeting novel boron carrier. Neuro-oncology advances 6 (1) (2024)
Yoshiki Fujikawa, Shinji Kawabata, Kohei Tsujino, Hironori Yamada, Hideki Kashiwagi, Ryokichi Yagi, Ryo Hiramatsu, Naosuke Nonoguchi, Toshihiro Takami, Akinori Sasaki, Naonori Hu, Takushi Takata, Hiroki Tanaka, Minoru Suzuki, Masahiko Wanibuchi
Boron neutron capture therapy delays the decline in neurological function in a mouse model of metastatic spinal tumors. Cancer science 115 (8) (2024)
Naonori Hu, Taiki Nakamura, Ryusuke Kataura, Keita Suga, Tetsuya Mukawa, Kazuhiko Akita, Akinori Sasaki, Mai Nojiri, Nishiki Matsubayashi, Takushi Takata, Hiroki Tanaka, Keiji Nihei, Koji Ono
Implementation of optically simulated luminescent dosimeter for quality control of gamma ray dose of an accelerator-based neutron source. Journal of applied clinical medical physics (2024)
Kohei Tsujino, Hideki Kashiwagi, Kai Nishimura, Yoshiki Fujikawa, Ryo Kayama, Yusuke Fukuo, Ryo Hiramatsu, Naosuke Nonoguchi, Takushi Takata, Hiroki Tanaka, Minoru Suzuki, Naonori Hu, Koji Ono, Masahiko Wanibuchi, Kei Nakai, Hiroyuki Nakamura, Shinji Kawabata
Nonclinical pharmacodynamics of boron neutron capture therapy using direct intratumoral administration of a folate receptor targeting novel boron carrier. Neuro-oncology advances 6 (1) (2024)
Hideki Kashiwagi, Yoshihide Hattori, Shinji Kawabata, Ryo Kayama, Kohei Yoshimura, Yusuke Fukuo, Takuya Kanemitsu, Hiroyuki Shiba, Ryo Hiramatsu, Toshihiro Takami, Takushi Takata, Hiroki Tanaka, Tsubasa Watanabe, Minoru Suzuki, Naonori Hu, Shin-Ichi Miyatake, Mitsunori Kirihata, Masahiko Wanibuchi
Multi-Targeted Neutron Capture Therapy Combined with an 18 kDa Translocator Protein-Targeted Boron Compound Is an Effective Strategy in a Rat Brain Tumor Model. Cancers 15 (4) (2023)
Hideki Kashiwagi, Yoshihide Hattori, Shinji Kawabata, Ryo Kayama, Kohei Yoshimura, Yusuke Fukuo, Takuya Kanemitsu, Hiroyuki Shiba, Ryo Hiramatsu, Toshihiro Takami, Takushi Takata, Hiroki Tanaka, Tsubasa Watanabe, Minoru Suzuki, Naonori Hu, Shin-Ichi Miyatake, Mitsunori Kirihata, Masahiko Wanibuchi
Multi-Targeted Neutron Capture Therapy Combined with an 18 kDa Translocator Protein-Targeted Boron Compound Is an Effective Strategy in a Rat Brain Tumor Model. Cancers 15 (4) (2023)
Andrea Monti Hughes, Naonori Hu
Optimizing Boron Neutron Capture Therapy (BNCT) to Treat Cancer: An Updated Review on the Latest Developments on Boron Compounds and Strategies. Cancers 15 (16) (2023)
Hideki Kashiwagi, Yoshihide Hattori, Shinji Kawabata, Ryo Kayama, Kohei Yoshimura, Yusuke Fukuo, Takuya Kanemitsu, Hiroyuki Shiba, Ryo Hiramatsu, Toshihiro Takami, Takushi Takata, Hiroki Tanaka, Tsubasa Watanabe, Minoru Suzuki, Naonori Hu, Shin-Ichi Miyatake, Mitsunori Kirihata, Masahiko Wanibuchi
Multi-Targeted Neutron Capture Therapy Combined with an 18 kDa Translocator Protein-Targeted Boron Compound Is an Effective Strategy in a Rat Brain Tumor Model. Cancers 15 (4) (2023)
Yoshiki Fujikawa, Yusuke Fukuo, Kai Nishimura, Kohei Tsujino, Hideki Kashiwagi, Ryo Hiramatsu, Naosuke Nonoguchi, Motomasa Furuse, Toshihiro Takami, Naonori Hu, Shin-Ichi Miyatake, Takushi Takata, Hiroki Tanaka, Tsubasa Watanabe, Minoru Suzuki, Shinji Kawabata, Hiroyuki Nakamura, Masahiko Wanibuchi
Evaluation of the Effectiveness of Boron Neutron Capture Therapy with Iodophenyl-Conjugated closo -Dodecaborate on a Rat Brain Tumor Model. Biology 12 (9) (2023)
Mai Nojiri, Takushi Takata, Naonori Hu, Yoshinori Sakurai, Minoru Suzuki, Hiroki Tanaka
Development and evaluation of dose calculation algorithm with a combination of Monte Carlo and point-kernel methods for boron neutron capture therapy. Biomedical physics & engineering express 9 (3) (2023)
Naonori Hu, Hiroki Tanaka, Ryo Kakino, Syuushi Yoshikawa, Mamoru Miyao, Kazuhiko Akita, Kayako Isohashi, Teruhito Aihara, Keiji Nihei, Koji Ono
Evaluation of a treatment planning system developed for clinical boron neutron capture therapy and validation against an independent Monte Carlo dose calculation system. Radiation oncology (London, England) 16 (1) (2021)
Akinori Sasaki, Hiroki Tanaka, Takushi Takata, Yuki Tamari, Tsubasa Watanabe, Naonori Hu, Shinji Kawabata, Yoshihiro Kudo, Toshinori Mitsumoto, Yoshinori Sakurai, Minoru Suzuki
Development of an irradiation method for superficial tumours using a hydrogel bolus in an accelerator-based BNCT. Biomedical physics & engineering express 8 (1) (2021)